Skip to main content

Table 4 Correlations between HRQoL and HU measures: EU and Non-EU cohorts

From: Use of health-related quality of life measures to predict health utility in postmenopausal osteoporotic women: results from the Multiple Outcomes of Raloxifene Evaluation study

Non-EU cohort EU cohort
OPAQ vs. HUI NHP vs. HUI QualEFFO vs. EQ-5D NHP vs. EQ-5D
OPAQ domain r NHP Domain r QualEFFO domain r NHP domain r
Walking/Bending 0.524 Emotional reaction −0.393 Pain 0.571 Emotional reaction −0.561
Standing/Sitting 0.490 Energy −0.477 Daily activity 0.713 Energy −0.593
Dressing/Reaching 0.325 Physical mobility −0.506 Mobility 0.657 Physical mobility −0.596
Household/Self care 0.335 Pain −0.578 General health 0.558 Pain −0.650
Transfers 0.416 Sleep −0.386 Mental health 0.540 Sleep −0.335
Usual work 0.400 Social interaction −0.272 Overall QOL 0.515 Social interaction −0.347
Fear of falls 0.456       
Level of tension 0.342       
Body image 0.265       
Independence 0.405       
Back pain 0.495       
Fatigue 0.444       
Social activity 0.116*       
Support, family and friends 0.093*       
  1. Abbreviations: EU European Union, HUI Health Utility Index, NHP Nottingham Health Profile, Non-EU Non-European Union, OPAQ Osteoporosis Assessment Questionnaire, QOL quality of life, QualEFFO EU Foundation of Osteoporosis Quality-of-Life Assessment, r = Pearson’s correlation coefficient estimate.
  2. Scoring: OPAQ scores: 0 (worst) - 100 (best), HUI scores: 0 (worst) - 1.0 (best), NHP scores: 0 (best) - 100 (worst), EQ-5D scores: 0 (worst) - 1.0 (best). QualEFFO scores (54-item QualEFFO): 0 (worst) - 100 (best).
  3. *p < 0.05, p < 0.0001 for all other coefficients.